Stay updated on Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a dedicated Locations section showing Pennsylvania as a study site, and updated the page revision to v3.3.3. Removed the Pennsylvania Locations subheading and HHS Vulnerability Disclosure link, and replaced v3.3.2 with v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-22T22:02:52.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2 instead of v3.3.1. There are no changes to study content, eligibility criteria, results, or site functionality.
    Difference
    0.1%
    Check dated 2025-12-01T11:48:26.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Revision history shows an addition of Revision: v3.3.1 and removal of Revision: v3.2.0, a minor meta-update; no study content is affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:38:31.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Removal of the site-wide government funding/operating-status notice. The core trial information, eligibility criteria, and study results remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:23:44.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The new screenshot shows only minor visual/layout adjustments with no changes to core study details such as eligibility criteria, interventions, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:00:05.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    - The page now includes a notice about potential government funding lapse and current operating status, plus a link to the NIH Clinical Center and opm.gov for updates. - The version is updated from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T09:22:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.